RGEN Cash-Secured Put Strategy
RGEN (Repligen Corporation), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand.
RGEN (Repligen Corporation) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $8.29B, a trailing P/E of 161.19, a beta of 1.08 versus the broader market, a 52-week range of 100.99-175.77, average daily share volume of 1.1M, a public-listing history dating back to 1986, approximately 2K full-time employees. These structural characteristics shape how RGEN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.08 places RGEN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 161.19 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a cash-secured put on RGEN?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current RGEN snapshot
As of June 29, 2026, spot at $137.61, ATM IV 55.20%, IV rank 4.82%, expected move 15.83%. The cash-secured put on RGEN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this cash-secured put structure on RGEN specifically: RGEN IV at 55.20% is on the cheap side of its 1-year range, which means a premium-selling RGEN cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 15.83% (roughly $21.78 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RGEN expiries trade a higher absolute premium for lower per-day decay. Position sizing on RGEN should anchor to the underlying notional of $137.61 per share and to the trader's directional view on RGEN stock.
RGEN cash-secured put setup
The RGEN cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RGEN near $137.61, the first option leg uses a $130.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RGEN chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RGEN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $130.00 | $3.48 |
RGEN cash-secured put risk and reward
- Net Premium / Debit
- +$347.50
- Max Profit (per contract)
- $347.50
- Max Loss (per contract)
- -$12,651.50
- Breakeven(s)
- $126.53
- Risk / Reward Ratio
- 0.027
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
RGEN cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on RGEN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$12,651.50 |
| $30.44 | -77.9% | -$9,608.98 |
| $60.86 | -55.8% | -$6,566.45 |
| $91.29 | -33.7% | -$3,523.93 |
| $121.71 | -11.6% | -$481.41 |
| $152.14 | +10.6% | +$347.50 |
| $182.56 | +32.7% | +$347.50 |
| $212.99 | +54.8% | +$347.50 |
| $243.41 | +76.9% | +$347.50 |
| $273.84 | +99.0% | +$347.50 |
When traders use cash-secured put on RGEN
Cash-secured puts on RGEN earn premium while a trader waits to acquire RGEN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RGEN.
RGEN thesis for this cash-secured put
The market-implied 1-standard-deviation range for RGEN extends from approximately $115.83 on the downside to $159.39 on the upside. A RGEN cash-secured put lets a trader earn premium while waiting to acquire RGEN at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current RGEN IV rank near 4.82% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RGEN at 55.20%. As a Healthcare name, RGEN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RGEN-specific events.
RGEN cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RGEN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RGEN alongside the broader basket even when RGEN-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on RGEN carry tail risk when realized volatility exceeds the implied move; review historical RGEN earnings reactions and macro stress periods before sizing. Always rebuild the position from current RGEN chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on RGEN?
- A cash-secured put on RGEN is the cash-secured put strategy applied to RGEN (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With RGEN stock trading near $137.61, the strikes shown on this page are snapped to the nearest listed RGEN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are RGEN cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the RGEN cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 55.20%), the computed maximum profit is $347.50 per contract and the computed maximum loss is -$12,651.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RGEN cash-secured put?
- The breakeven for the RGEN cash-secured put priced on this page is roughly $126.53 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RGEN market-implied 1-standard-deviation expected move is approximately 15.83%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on RGEN?
- Cash-secured puts on RGEN earn premium while a trader waits to acquire RGEN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RGEN.
- How does current RGEN implied volatility affect this cash-secured put?
- RGEN ATM IV is at 55.20% with IV rank near 4.82%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.